Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

764.10INR
13 Sep 2019
Change (% chg)

Rs5.05 (+0.67%)
Prev Close
Rs759.05
Open
Rs762.40
Day's High
Rs766.00
Day's Low
Rs753.60
Volume
519,219
Avg. Vol
1,550,056
52-wk High
Rs981.50
52-wk Low
Rs697.20

Summary

Name Age Since Current Position

Manju Gupta

2017 Chairman of the Board

Vinita Gupta

51 2013 Chief Executive Officer, Executive Director

Kamal Sharma

2018 Non-Executive Vice Chairman of the Board

Sunil Makharia

2019 Interim Chief Financial Officer

Debabrata Chakravorty

2013 President – Global Sourcing & Contract Manufacturing

Rajendra Chunodkar

2019 President - Manufacturing Operations

Fabrice Egros

President - Asia Pacific & Japan

Naresh Gupta

President - API Plus & Global TB

Nicholas Hart

President - Specialty, Pharma

Rajender Kamboj

President - Novel Drug Discovery & Development

Cyrus Karkaria

2010 President - Biotechnology

Yashwant Mahadik

51 2018 President - Global Human Resources

Martin Mercer

President - Latin America

Rajeev Sibal

President - India Region Formulations

Alok Sonig

CEO - US Generics & Global R&D and Biosimilars

Thierry Volle

2015 President - Europe , Middle-East & Africa (EMEA)

Nilesh Gupta

2013 Managing Director, Executive Director

James Loerop

2017 Chief Corporate Development Officer

Sofia Mumtaz

2016 Head - Pipeline Management & Legal

Rajvardhan Satam

2019 Company Secretary

Jean-Luc Belingard

2015 Non-Executive Independent Director

Dileep Choksi

69 2012 Non-Executive Independent Director

K. Mada

85 Non-Executive Independent Director

Christine Mundkur

50 2019 Additional Non-Executive Independent Director

R. Shah

88 2005 Non-Executive Independent Director

Richard Zahn

2010 Non-Executive Independent Director

Biographies

Name Description

Manju Gupta

Mrs. Manju Deshbandhu Gupta is Chairman of the Board of Lupin Limited. She is a graduate in arts, She is one of the promoters of the company with a wide business experience.

Vinita Gupta

Ms. Vinita D. Gupta is Chief Executive Officer, Executive Director of Lupin Limited. She is a graduate in pharmacy from the University of Mumbai and an MBA from the Kellogg School of Management at Northwestern University. She has been instrumental in formulating and executing the strategy that helped the Company to emerge as a global pharmaceutical powerhouse. Through a combination of organic growth and strategic acquistions, Ms. Vinita has led the Company’s global expansion plans. She founded the Company’s offices in the United States. Ms. Vinita has been regularly named by Forbes Asia in its Top 50 Power Business Women listings for Asia Pacific. She was also recognized by Business Today Hall of Fame - Most Powerful Women in Business in 2016 and was recently named Outstanding Business Woman Leader of the Year by CNBC India Business Leader Awards. Ms. Vinita was the winner of the inaugural EY, U.S. 2012 Family Business Award of Excellence and EY Entrepreneur of the Year® 2012 award winner for Health Services and Technology in Maryland. During the year 2017, Ms. Vinita was appointed to the Board for Intrexon Corporation, USA. She is also a member of the Global Advisory Board at the Kellogg School of Management at Northwestern University.

Kamal Sharma

Dr. Kamal K. Sharma, Ph.D. is re designated as Non-Executive Vice Chairman of the Board of the company effective September 28, 2018. He is no longer Executive Vice Chairman of the Board of Lupin Limited effective October 1,2018. He had been associated with the Lupin Group for over three decades during which, he has effectively led the senior leadership team and was involved in setting vision of the Company, building strategy and mentoring the management. The role of Dr. Sharma changed from Executive to Non-Executive.

Sunil Makharia

Debabrata Chakravorty

Rajendra Chunodkar

Fabrice Egros

Naresh Gupta

Nicholas Hart

Rajender Kamboj

Cyrus Karkaria

Yashwant Mahadik

Mr. Yashwant Mahadik is an President - Global Human Resources of the Company. He is a seasoned HR professional with nearly three decades of experience across diverse sectors such as consumer and healthcare in global organizations. His last assignment was with Sun Pharmaceuticals as Global Chief Human Resources Officer prior to which he held HR roles with increasing responsibilities at companies like Philips, Johnson & Johnson, AstraZeneca and Colgate Palmolive. Yash brings to Lupin rich experience in HR and business transformation across global markets. He has an MBA in General Management and International Human Resource Management from University of Sheffield, United Kingdom, and is a Certified Associate Executive Coach from Franklin Covey and Results Coaching System, USA. Yash is a renowned thought leader in HR and has collaborated with leading global academicians to conceptualize and execute strategic initiatives in the field of Human Resource Management.

Martin Mercer

Rajeev Sibal

Alok Sonig

Thierry Volle

Dr. Thierry Volle is President - Europe, Middle-East & Africa (EMEA) of the Company. At Lupin, Thierry will be responsible for the Company's growth and development in Europe , Russia & CIS, and Middle-East and African markets. He will be based at Lupin's European headquarters in Zug, Switzerland. Thierry joins Lupin from Vifor Pharma where he was the head of EU & International business operations. Prior to that, he was at Wyeth and worked his way through multiple roles of increasing responsibility in Europe as well as the corporate headquarters in St. Davids, PA. Thierry has extensive international experience in building and growing specialty pharmaceuticals businesses across markets specifically in EMEA, with a focus on business & market development, integration & change management and product portfolio management. He holds a Business diploma from Institut Supérieur de Gestion and a Master's degree in Computer Science from Centre d'études supérieures industrielles- Centrale, Paris and has also completed various Executive Programs at the Harvard School of Public Health , INSEAD and EPFL to name a few.

Nilesh Gupta

Mr. Nilesh Deshbandhu Gupta is an Managing Director, Executive Director of Lupin Limited. He is a chemical engineer from UDCT, Mumbai, and a graduate with honours from the Wharton School, U.S.A. Mr. Gupta had demonstrated exemplary performance in integrating and leading the diversified portfolio and ably contributed to the growth and profitability of the Company. He directed the IP strategy of the Company towards achieving a niche position for chosen products. Mr. Gupta is a sound business leader and team builder.

James Loerop

Sofia Mumtaz

Rajvardhan Satam

Jean-Luc Belingard

Mr. Jean-Luc Belingard is Non-Executive Independent Director of the Company. He started his career in 1974 in Sales & Marketing with Merck, Sharp and Dohme (France). In 1981, he moved to Merck, Sharp and Dohme (USA) as Senior Director, Promotion Planning. In 1983, he joined F. Hoffman-La Roche, Basel, Switzerland as Associate Director, International Marketing. During 1990-1998, he was Member of the Executive Committee, F. Hoffman-La Roche Ltd. and Chief Executive Officer, Roche Diagnostics, Basel, Switzerland. From 1999 to 2001, he was Chief Executive Officer, BioMerieux-Pierre Fabre, France. During 2002-2010, he was Chairman and Chief Executive Officer, Ipsen Group, France. In 2011, he joined BioMerieux S.A. as Chief Executive Officer and became its Chairman in April 2014. Mr. Belingard has been conferred upon prestigious National Awards viz. ‘Chevalier de I’Ordre National du Merite’ and ‘Chevalier de la Legion d’Honneur’. Presently, Mr. Belingard is Member of the Board of Directors of Laboratory Corporation of America (USA), Stallergenes (France/USA), Transgene (France) and Laboratoire Pierre Fabre, (France). Since 2014, he is Member of the Bill and Melinda Gates Foundation. Since 1988, he is Foreign Trade Advisor to the French Government. He has served as Member of the Board of Directors of several leading corporates in the U.S., France, Germany and Japan, and has been actively involved with various Associations, Institutions and Advisory Boards in different capacities.

Dileep Choksi

Mr. Dileep Chinubhai Choksi is Non-Executive Independent Director of Lupin Limited., since October 23, 2012. Mr. Dileep C. Choksi is a leading Chartered Accountant, qualified lawyer and a Cost Accountant with over 35 years of experience. His areas of specialisation include tax planning and structuring for domestic and international clients, including expatriates, finalising collaborations and joint ventures, executive advisory and decision support, corporate restructuring with a focus on start-ups, turnaround and change management strategies and analysing tax impact of various instruments. Mr. Choksi advises some of India’s large business houses on various strategic matters and multinational clients on cross border structuring. He has set up C. C. Chokshi Advisors Pvt. Ltd., the activities of which aim to provide complete solutions for all business requirements.

K. Mada

Dr. K. U. Mada Ph.D. is Non-Executive Independent Director of Lupin Limited. He is an eminent economist and was a development banker. He holds a Ph.D. (Economics) degree from Bombay University and a certificate in financial management from Jamnalal Bajaj Institute, Mumbai. He taught Economics at Jai Hind College, Mumbai, for seven years. Thereafter, he worked for the Reserve Bank of India and Industrial Development Bank of India (IDBI) and held senior positions, including as Executive Director, IDBI, and a stint as chief of a bank. Dr. Mada was Chairman/Member of several committees constituted by lDBI/other financial institutions and the Government of India. He brought out books, including ‘A Journey through Development Banking (2005)’ and published articles in wellknown journals. He represented lDBI as Speaker/participant at several national and international conferences/seminars on economic, corporate and institutional affairs. He was a visiting faculty at management institutes. Dr. Mada was on the boards of corporate entities and all-India financial institutions, including the Management Development Institute, Gurgaon.

Christine Mundkur

Ms. Christine Mundkur is Additional Non-Executive Independent Director of the Company., effective April 1, 2019. Pursuant to the provisions of Sections 149 and 152 of the Act, Ms. Mundkur holds office up to the date of the forthcoming Annual General Meeting (AGM). Ms. Mundkur has served as Chief Executive Officer and has held senior leadership positions in large multinational pharma companies. She holds a J.D. from the St. Louis University School of Law and a B.S. degree in chemistry from St. Louis University. Notices under Sections 152 and 160(1) of the Act, have been received from certain Members proposing her name for appointment as Director.

R. Shah

Mr. R. A. Shah is Non-Executive Independent Director of Lupin Limited. He is an eminent Solicitor and senior partner of M/s. Crawford Bayley & Company, a leading firm of Solicitors and Advocates in Mumbai. He specialises in a broad spectrum of Corporate Laws in general, with special focus on foreign investments, joint ventures, technology and license agreements, intellectual property rights, mergers and acquisitions, competition law and insider trading regulations. Mr. Shah is a member of the Managing Committee of Bombay Chamber of Commerce and Indo German Chamber of Commerce.

Richard Zahn

Mr. Richard A. Zahn is Non-Executive Independent Director of Lupin Limited. He is a B. S. (Business Administration) with Honors, Kansas State Teachers College, Kansas. He has completed Executive Education with Amos Tuck School, Dartmouth University, Harvard/MIT Program on Negotiation, The Wharton School, University of Pennsylvania, National Association of Corporate Directors - Certificate of Director Education. Mr. Zahn has also completed program in Executive Leadership, Cornell University. Mr. Richard is the Managing Partner of HMJ Global Partners, a corporate governance and not-for-profit public policy advisory group. With more than 30 years of experience in the biotechnology and pharmaceutical industries, he is an established leader and strategist in healthcare research and development, marketing management, managed care, and human resources. He is widely recognised as an insightful speaker on economic and policy issues. Mr. Richard was President of Schering Laboratories, U.S., Director, Schering Corporation and Corporate Vice President of Schering-Plough Corporation, a global researchbased company engaged in the discovery, development,manufacturing and marketing of pharmaceutical, biotechnology and healthcare prescription pharmaceutical marketing arm for Schering-Plough. Mr. Richard spent 20 years at Johnson & Johnson. Mr. Richard has focused his efforts on rural economic development and public policy. He has received several awards for his devoted work towards various organisations and charities with particular focus on health care and minority issues.